Tag Archives: STJ

Top 10 Low Price Stocks To Watch For 2019

Heart diseasestill claims the lives of around 600,000 Americans every year, and uncontrollable cholesterol plays a big role.EsperionTherapeutics Inc. (NASDAQ:ESPR)became oneof2017’s best-performing biotech stocks because it’s developing a drug that could lower this number.

Unfortunately, Esperion recently revealed some disturbing safety data from one of several ongoing late-stage clinical trials. The stock price was quickly cut in half, and there’s still a chance it could come back in a big way.

Does that make this risky biotech a buy on the dip?Let’s weigh opportunities against apparent risks to see if this stock makes sense at its new low price.

Image source: Getty Images.

Reasons to buy

Before Lipitor lost patent protection, it raked in $13 billion annually for Pfizer, and several similar drugs in the statin family were big sellers in their day. This class of drug is usually effective, but unpleasant side effects such as muscle weakness affect most patients to some degree. An estimated 15% of people treated for high cholesterol can’t get their scores low enough with statins because some form of intolerance limits their dosage.

Top 10 Low Price Stocks To Watch For 2019: Abengoa Yield plc(ABY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ArtByte (ABY) is a proof-of-work (PoW) coin that uses the Scrypt hashing algorithm. It was first traded on May 1st, 2014. ArtByte’s total supply is 792,537,250 coins. ArtByte’s official website is www.artbyte.me. ArtByte’s official Twitter account is @artbyteme and its Facebook page is accessible here. The Reddit community for ArtByte is /r/ArtByte and the currency’s Github account can be viewed here.

  • [By Logan Wallace]

    ArtByte (CURRENCY:ABY) traded up 10.8% against the dollar during the 1-day period ending at 20:00 PM ET on June 14th. ArtByte has a market capitalization of $3.84 million and approximately $13,004.00 worth of ArtByte was traded on exchanges in the last 24 hours. One ArtByte coin can currently be purchased for $0.0048 or 0.00000073 BTC on popular cryptocurrency exchanges including Bittrex, Cryptopia and LiteBit.eu. Over the last week, ArtByte has traded 16.9% lower against the dollar.

Top 10 Low Price Stocks To Watch For 2019: SigmaTron International, Inc.(SGMA)

Advisors’ Opinion:

  • [By Max Byerly]

    Media coverage about SigmaTron International (NASDAQ:SGMA) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. SigmaTron International earned a coverage optimism score of 0.25 on Accern’s scale. Accern also gave news coverage about the technology company an impact score of 47.5987310031013 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Top 10 Low Price Stocks To Watch For 2019: Greenhill & Co., Inc.(GHL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Greenhill & Co. (GHL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Greenhill & Co., Inc. (GHL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Greenhill & Co. (NYSE: GHL) is one of 31 publicly-traded companies in the “Security brokers & dealers” industry, but how does it compare to its competitors? We will compare Greenhill & Co. to related businesses based on the strength of its valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Top 10 Low Price Stocks To Watch For 2019: Fulton Financial Corporation(FULT)

Advisors’ Opinion:

  • [By Max Byerly]

    Boenning Scattergood reaffirmed their hold rating on shares of Fulton Financial (NASDAQ:FULT) in a research note published on Friday.

    FULT has been the subject of several other reports. Zacks Investment Research upgraded Fulton Financial from a sell rating to a hold rating in a report on Thursday, April 5th. BidaskClub downgraded Fulton Financial from a buy rating to a hold rating in a report on Wednesday, April 4th. Hovde Group reiterated a hold rating and issued a $18.00 price objective on shares of Fulton Financial in a report on Monday, April 23rd. DA Davidson initiated coverage on Fulton Financial in a research note on Monday, March 26th. They set a neutral rating and a $18.00 price target for the company. Finally, Barclays cut their price target on Fulton Financial from $19.00 to $18.00 and set an underweight rating for the company in a research note on Thursday, April 19th. Two analysts have rated the stock with a sell rating and nine have given a hold rating to the stock. Fulton Financial presently has a consensus rating of Hold and a consensus price target of $18.29.

  • [By Joseph Griffin]

    Hsbc Holdings PLC lessened its stake in Fulton Financial Corp (NASDAQ:FULT) by 88.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 28,236 shares of the bank’s stock after selling 213,318 shares during the quarter. Hsbc Holdings PLC’s holdings in Fulton Financial were worth $502,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Fulton Financial (FULT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Fulton Financial Corp (NASDAQ:FULT) – Analysts at DA Davidson lowered their Q1 2019 EPS estimates for shares of Fulton Financial in a research report issued to clients and investors on Wednesday, July 18th. DA Davidson analyst R. Gunther now forecasts that the bank will post earnings of $0.29 per share for the quarter, down from their prior estimate of $0.30. DA Davidson currently has a “Neutral” rating and a $18.00 price target on the stock. DA Davidson also issued estimates for Fulton Financial’s Q3 2019 earnings at $0.35 EPS.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Fulton Financial (FULT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Low Price Stocks To Watch For 2019: InfraREIT, Inc.(HIFR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Reaves W H & Co. Inc. trimmed its holdings in InfraREIT (NYSE:HIFR) by 18.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,342,026 shares of the real estate investment trust’s stock after selling 303,392 shares during the quarter. Reaves W H & Co. Inc. owned approximately 3.05% of InfraREIT worth $26,076,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on InfraREIT (HIFR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Low Price Stocks To Watch For 2019: ThyssenKrupp AG (TYEKF)

Advisors’ Opinion:

  • [By ]

    United Technologies’ Otis division manufactures and services elevators, escalators, and other people moving devices. The business is reasonably attractive since there is a fair degree of concentration. Four major companies, Kone Oyj (OTCPK:KNYJF) (OTCPK:KNYJY), ThyssenKrupp (OTCPK:TYEKF) (OTCPK:TKAMY), Schindler (OTCPK:SHLAF) (OTC:SHNDY), and Otis, account for over 50% market share. The main long-term drivers of the industry are urbanization. As you might guess, elevator demand is strongest in dense urban environments where almost every building is multi-story.

Top 10 Low Price Stocks To Watch For 2019: St. Jude Medical, Inc.(STJ)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media headlines about St Jude Medical (NYSE:STJ) have been trending positive recently, according to Accern. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. St Jude Medical earned a coverage optimism score of 0.26 on Accern’s scale. Accern also gave media coverage about the medical technology company an impact score of 46.7237518599623 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Stephan Byrd]

    Deutsche Bank upgraded shares of St. James’s Place (LON:STJ) to a buy rating in a research report released on Thursday. They currently have GBX 1,430 ($19.19) target price on the stock, up from their prior target price of GBX 1,310 ($17.58).

Top 10 Low Price Stocks To Watch For 2019: Columbia Sportswear Company(COLM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Columbia Sportswear (COLM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Brasada Capital Management LP grew its stake in shares of Columbia Sportswear (NASDAQ:COLM) by 25.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,669 shares of the textile maker’s stock after purchasing an additional 1,148 shares during the quarter. Brasada Capital Management LP’s holdings in Columbia Sportswear were worth $433,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Columbia Sportswear (NASDAQ:COLM) hit a new 52-week high and low during mid-day trading on Tuesday . The stock traded as low as $88.86 and last traded at $88.27, with a volume of 4020 shares traded. The stock had previously closed at $87.29.

Top 10 Low Price Stocks To Watch For 2019: CoreSite Realty Corporation(COR)

Advisors’ Opinion:

  • [By Shane Hupp]

    CORION (CURRENCY:COR) traded down 6.2% against the U.S. dollar during the 1 day period ending at 13:00 PM Eastern on June 1st. In the last seven days, CORION has traded up 0.5% against the U.S. dollar. One CORION token can currently be purchased for $0.12 or 0.00001572 BTC on major cryptocurrency exchanges. CORION has a market cap of $0.00 and $4,199.00 worth of CORION was traded on exchanges in the last day.

  • [By Joseph Griffin]

    CORION (CURRENCY:COR) traded down 7% against the US dollar during the one day period ending at 14:00 PM Eastern on July 1st. Over the last week, CORION has traded 6.7% lower against the US dollar. One CORION token can currently be bought for approximately $0.0601 or 0.00000950 BTC on exchanges. CORION has a total market capitalization of $0.00 and $960.00 worth of CORION was traded on exchanges in the last day.

  • [By ]

    In the Lightning Round, Cramer was bullish on Align Technology (ALGN) , Berkshire Hathaway (BRK.A)   (BRK.B) , Criticare Systems Inc.  (CMD) , Thermo Fisher Scientific (TMO) , IAC Interactive (IAC) and CoreSite Realty (COR) .

  • [By Shane Hupp]

    CORION (CURRENCY:COR) traded 0.1% higher against the dollar during the 24 hour period ending at 11:00 AM Eastern on June 12th. One CORION token can currently be purchased for about $0.0711 or 0.00001050 BTC on exchanges. Over the last week, CORION has traded down 38.7% against the dollar. CORION has a total market capitalization of $0.00 and $1,404.00 worth of CORION was traded on exchanges in the last day.

  • [By ]

    CoreSite Realty (COR) : “The data centers have been hot, but the REITS have not. I’m a buyer of this stock, not a seller.”

    Hi-Crush Partners (HCLP) : “This sector has gotten way too hot.”

Top 10 Low Price Stocks To Watch For 2019: Corning Incorporated(GLW)

Advisors’ Opinion:

  • [By Steve Symington]

    Corning Incorporated(NYSE:GLW)released solid first-quarter 2018 results on Tuesday morning. The glass technologist met or exceeded expectations in each of its five business segments, and it clarified its growth targets both for the coming year and longer term.

  • [By Ethan Ryder]

    News stories about Corning (NYSE:GLW) have trended somewhat positive on Saturday, according to Accern Sentiment. The research group rates the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Corning earned a media sentiment score of 0.14 on Accern’s scale. Accern also assigned headlines about the electronics maker an impact score of 46.5441860761987 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Leo Sun]

    Shares of Corning (NYSE:GLW) surged 11% on July 25 after the specialty components maker posted solid second quarter numbers. Its revenue rose 10% year-over-year to$2.7 billion, beating estimates by $60 million and marking the company’s strongest growth in five quarters. Corning’s core sales — which exclude currency impacts and one-time gains or charges — rose 9% to $2.8 billion. Both its reported and core sales rose 10% sequentially.

  • [By Rich Smith]

    2018 has not been a fun year to own Corning (NYSE:GLW) stock.

    Hurt by fickle prices for its most visible product — the glass panes used to create the displays on smartphones and flat-panel TVs — Corning stock has lost more than 10% of its share price over the past year, even as the S&P 500 has gone up 10%. The stock’s done even worse since this year began, hitting a highnear $35 a share in January, but losing nearly $10 of that to hit and currently sitting at its lows of the year — just $26.35 per share, and a near-25% drop.

Hot Casino Stocks For 2019

Amaya’s stock has been on a wild roller coaster ride this year, with catalysts ranging from the CEO (David Baazov) being accused of insider trading, to takeover rumors, to failed mergers and now a formal bid by the aforementioned CEO. There have certainly been a lot of hopes and headaches, but I believe there is a strong underlining long case to be made on Amaya. I wrote a blog post about it the day before it released its Q3 earnings, my basic argument was that it is intrinsically undervalued due to market overreaction on merger discussions and there was still the possibility of a buyout by the former CEO at a significant upside. It seemed like a win-win. Well, when the earnings were released, not only were the results impressive but Baazov launched a formal bid at C$24 per share (approximately US$18) or a 30% upside from the previous Friday’s Close. Whether this private takeover succeeds or not, this stock is poised for significant long term growth.

Amaya (NASDAQ:AYA) runs the world’s largest online gaming (casino) empire in the world. It runs many valuable brand names especially in the online poker business (PokerStars and Fulltilt) but is now increasingly moving into sports betting and other online casino games. It is also the fastest growing and most well positioned to take advantage of online gambling legalization as well as the inherent scalability of the internet. This is a company which has seen its revenues increase from below US$200M just a few years ago to over US$1.2 BILLION for the trailing twelve months. Reviewing its results and its future growth prospects, it will be clear that this firm is undervalued.

Hot Casino Stocks For 2019: Eros International PLC(EROS)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Eros International (NYSE:EROS) Q4 2018 Earnings Conference CallJun. 27, 2018 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Eros International plc (NYSE:EROS)’s share price was up 6.8% during mid-day trading on Wednesday . The company traded as high as $14.50 and last traded at $14.10. Approximately 936,285 shares changed hands during mid-day trading, an increase of 135% from the average daily volume of 397,949 shares. The stock had previously closed at $13.20.

  • [By Garrett Baldwin]

    The secret to becoming a millionaire, of course, is getting out in front of a major investment trend before it becomes mainstream. In 2017, it was Bitcoin and cryptocurrencies. But this year, it’s a taboo investment that is creating millionaires all across North America. Tap into the “green rush,” and prepare to become a “Marijuana millionaire.” Learn how to get started right here.

    The Top Stock Market Stories for Wednesday
    U.S. President Donald Trump is facing criticism after threatening to ramp up taxes on Harley-Davidson Inc. (NYSE: HOG). The iconic motorcycle producer said it will move parts of its production overseas in order to avoid tariffs from the European Union. Trump threatened to increase taxes on the firm. “Surprised that Harley-Davidson, of all companies, would be the first to wave the White Flag,” Trump tweeted Tuesday. “I fought hard for them and ultimately they will not pay tariffs selling into the E.U., which has hurt us badly on trade, down $151 Billion. Taxes just a Harley excuse – be patient!” Earlier this month,Microsoft Corp.(Nasdaq:MSFT) launched a $7.5 billion takeover of the web-based hosting service GitHub. The acquisition, orchestrated by Microsoft CEO Satya Nadella, brought out critics who claim that GitHub lacks any real profit potential forMicrosoft stock. Here’s why those critics are wrong… and why MSFT is a buy. Facebook Inc. (Nasdaq: FB) has reversed its policy on cryptocurrency ads. The social media giant says that it will permit marketing from “pre-approved advisers.” According to TechCrunch, the company will still ban ads pushing binary options and initial coin offerings. The report goes on to explain that cryptocurrency scams cost customers more than $500 million in just January and February 2018 alone.
    Four Stocks to Watch Today: ORCL, FB, GOOGL, BA
    Oracle Corp. (NYSE: ORCL) were largely flat despite a strong earnings report after the bell yesterday. The cloud computing giant reported EPS of $0.99

Hot Casino Stocks For 2019: St. Jude Medical, Inc.(STJ)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media headlines about St Jude Medical (NYSE:STJ) have been trending positive recently, according to Accern. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. St Jude Medical earned a coverage optimism score of 0.26 on Accern’s scale. Accern also gave media coverage about the medical technology company an impact score of 46.7237518599623 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Stephan Byrd]

    Deutsche Bank upgraded shares of St. James’s Place (LON:STJ) to a buy rating in a research report released on Thursday. They currently have GBX 1,430 ($19.19) target price on the stock, up from their prior target price of GBX 1,310 ($17.58).

Hot Casino Stocks For 2019: North American Energy Partners, Inc.(NOA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Core Laboratories (NYSE: CLB) and North American Construction Group (NYSE:NOA) are both oils/energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations and earnings.

  • [By Ethan Ryder]

    Mammoth Energy Services (NASDAQ: TUSK) and North American Construction Group (NYSE:NOA) are both small-cap oils/energy companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends.

Hot Casino Stocks For 2019: WGL Holdings Inc(WGL)

Advisors’ Opinion:

  • [By Stephan Byrd]

    WGL Holdings Inc (NYSE:WGL)’s share price reached a new 52-week high during trading on Thursday . The stock traded as high as $88.75 and last traded at $88.72, with a volume of 377688 shares traded. The stock had previously closed at $88.56.

  • [By Shane Hupp]

    Franklin Resources Inc. purchased a new stake in shares of WGL Holdings Inc (NYSE:WGL) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 28,373 shares of the utilities provider’s stock, valued at approximately $2,374,000. Franklin Resources Inc. owned about 0.06% of WGL as of its most recent SEC filing.

Best Medical Stocks To Own Right Now

Retirement isn’t the sort of thing most of us can just jump into. Rather, it requires long-term planning and a healthy level of savings to boot. And while a large chunk of Americans are taking steps to build their nest eggs, there’s one important piece of the puzzle most workers are missing: planning for healthcare costs during their golden years.

Only 12% of working adults have taken steps to address or plan for medical expenses in retirement, according to data from the Empower Institute and Brightwork Partners. Furthermore, more than half of Americans admit they know little to nothing about what Medicare costs. If your goal is to retire with a degree of financial security, you’ll need to start educating yourself on the reality of senior healthcare. And the sooner you do, the better a position you’ll be in to save for it.

IMAGE SOURCE: GETTY IMAGES.

Best Medical Stocks To Own Right Now: Celyad SA(CYAD)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints.
    MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday.
    Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday.
    Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday.
    Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday.
    Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec.
    Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading.
    Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session.
    LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire.
    HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

    Find out what's going

  • [By Lisa Levin]

    Breaking news

    Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis, Inc. (NASDAQ: ABAX) for $83 per share in cash.
    Boot Barn Holdings Inc (NYSE: BOOT) reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    CELYAD SA/ADR (NASDAQ: CYAD) reported launch of 1.8 million share offering.
    Verastem Inc (NASDAQ: VSTM) shares dropped 12 percent in pre-market trading after announcing a $35 million common stock offering.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
    Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
    Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
    RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
    Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
    Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
    Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
    CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M

Best Medical Stocks To Own Right Now: NBT Bancorp Inc.(NBTB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    NBT Bancorp (NASDAQ:NBTB) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on NBT Bancorp (NBTB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on NBT Bancorp (NBTB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Medical Stocks To Own Right Now: UnitedHealth Group Incorporated(UNH)

Advisors’ Opinion:

  • [By Paul Ausick]

    The Dow stock posting the largest daily percentage gain ahead of the close Monday was UnitedHealth Group Inc. (NYSE: UNH) which traded up 1.39% at $254.16. The stock’s 52-week range is $176.42 to $254.99, a new high set this afternoon. Volume was about 4% below the daily average of around 3.2 million. The company had no specific news.

  • [By ]

    So, nothing about trade wars, tariffs, currency devaluations, wars in Syria, or North Korea, or Iran from the occupier of the Oval Office. Perhaps partly as a result, the major U.S. equity indexes rose strongly for a second day, fueled by better than expected earnings by Netflix (NFLX) and helped along by stalwart U.S. corporations including UnitedHealth (UNH) , General Electric (GE) and Cisco (CSCO) .

  • [By Paul Ausick]

    UnitedHealth Group Inc. (NYSE: UNH) traded down 1.21% at $244.90. The stock’s 52-week range is $173.71 to $250.79. Volume was about half the daily average of 3.4 million. The company had no specific news Tuesday.

Best Medical Stocks To Own Right Now: Canadian National Railway Company(CNI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Canadian National Railway (CNI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Neha Chamaria]

    Investing for really long periods of time, however, becomes easier if you bet on industry stalwarts that have consistently rewarded shareholders and possess strong growth catalysts to keep them going for years to come. I can think of four such “forever” stocks right now: Canadian National Railway (NYSE:CNI), Waste Management (NYSE:WM), Mastercard (NYSE:MA), and Visa (NYSE:V).

  • [By Paul Ausick]

    GE got some good news this past week with an order for 200 locomotives from Canadian National Railway Co. (NYSE: CNI). The locomotives will be built at GE’s plant in Fort Worth, Texas, and deliveries to the rail operator will begin next year. The balance of the locomotives will be delivered in 2019 and 2020.

  • [By Neha Chamaria]

    Canadian National Railway (NYSE:CNI) is facing a unique problem: too much demand that it can’t seem to handle. Severe capacity shortages and delay in deliveries last quarter proved costly for the railroad, as evidenced by its just released first-quarter earnings report.

  • [By Joseph Griffin]

    Shares of Canadian National Railway (TSE:CNR) (NYSE:CNI) have been given an average recommendation of “Buy” by the eleven research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is C$109.36.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Canadian National Railway (CNI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Medical Stocks To Own Right Now: St. Jude Medical, Inc.(STJ)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media headlines about St Jude Medical (NYSE:STJ) have been trending positive recently, according to Accern. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. St Jude Medical earned a coverage optimism score of 0.26 on Accern’s scale. Accern also gave media coverage about the medical technology company an impact score of 46.7237518599623 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Stephan Byrd]

    Deutsche Bank upgraded shares of St. James’s Place (LON:STJ) to a buy rating in a research report released on Thursday. They currently have GBX 1,430 ($19.19) target price on the stock, up from their prior target price of GBX 1,310 ($17.58).

Best Medical Stocks To Own Right Now: USG Corporation(USG)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Warren Buffett likes to hold his stock positions for the long run, and his experience with USG (NYSE:USG) has been typical of his other long-term investments. The Oracle of Omaha started buying shares of the manufacturer of Sheetrock drywall and other building materials back in 2000, accumulating a sizable stake that has ballooned to more than 30% of the company. USG ended up going through bankruptcy in order to get a handle on its asbestos liability claims, but thanks largely to Buffett’s involvement, the building materials company not only survived bankruptcy but also saw share prices soar briefly on hopes that USG would once again fully participate in the then-strong housing boom.

  • [By Stephan Byrd]

    ValuEngine upgraded shares of USG (NYSE:USG) from a buy rating to a strong-buy rating in a report published on Tuesday.

    A number of other research analysts have also recently weighed in on the stock. Credit Suisse Group upgraded shares of USG from an underperform rating to a neutral rating and dropped their target price for the company from $35.00 to $24.00 in a research note on Friday, April 27th. Jefferies Group reiterated a hold rating and issued a $40.00 target price on shares of USG in a research note on Monday, April 23rd. SunTrust Banks boosted their target price on shares of USG from $42.00 to $44.00 and gave the company a hold rating in a research note on Tuesday, April 17th. Buckingham Research boosted their target price on shares of USG from $34.00 to $42.00 and gave the company a neutral rating in a research note on Monday, April 16th. Finally, Nomura boosted their target price on shares of USG from $39.00 to $44.00 and gave the company a neutral rating in a research note on Tuesday, March 27th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of $39.00.

  • [By Ethan Ryder]

    USG Co. (NYSE:USG) – Equities research analysts at SunTrust Banks reduced their Q3 2018 earnings per share estimates for shares of USG in a report issued on Monday, July 9th. SunTrust Banks analyst K. Hughes now forecasts that the construction company will post earnings of $0.57 per share for the quarter, down from their previous estimate of $0.61. SunTrust Banks currently has a “Hold” rating and a $44.00 price target on the stock. SunTrust Banks also issued estimates for USG’s FY2018 earnings at $2.05 EPS, Q3 2019 earnings at $0.71 EPS and FY2019 earnings at $2.53 EPS.

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    And while it may not always work out well to simply copy the moves other investors make, it can pay off to use their buying and selling moves as jumping-off points in your own research. We asked three real-world investors for their insight, and they wrote about two recent Buffett buys ofApple Inc.(NASDAQ:AAPL) andUSG Corporation(NYSE:USG), and a recent Baker Brothers buy ofHeron Therapeutics Inc(NASDAQ:HRTX).

  • [By Jordan Wathen]

    As USG Corporation (NYSE:USG) drags its feet on an offer to sell the company for $42 per share, Berkshire intends to use its 30.8% ownership stake to motivate its top brass to make a deal. Berkshire told Bloomberg it intends to vote its shares against USG’s board members who are up for re-election at this year’s annual meeting, a clear message that Buffett is ready to cash in, even if USG’s management and board are not.

Top 10 High Tech Stocks To Invest In Right Now

Shutterstock

Today I’m going to show you, hands-down, the easiest way to add rental real estate to your portfolio.

Don’t worry—you won’t have to leave your computer! Instead of hitting the streets to buy a four-plex or apartment building to rent out, we’re going to purchase a recession-proof real estate income stream straight from your online brokerage account.

And believe it or not, thanks to a current market anomaly, we can snag better deals online right now than we can in person. I’ll explain the details in a moment—including 2 stocks with yields that double what your average stock pays, and double-digit payout growth, too!

First, let me give you the lay of the residential real estate landscape.

A Bait-and-Switch Market

As I write, apartment vacancy rates across the US are tight—sitting at 6.9%, the lowest level in 24 years!

Top 10 High Tech Stocks To Invest In Right Now: Bayer Aktiengesellschaft (BAYZF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    We believe that the pharmaceutical sector has received too much negative attention. Despite the risks, a few companies offer good entry opportunities. In our previous article, we recommended Akorn. Today, we have analyzed Teva. We believe that the company is in a position to thrive in the generic market, and that it is priced very attractively. Yet, we don’t like management’s aggressive M&A strategy. We don’t like very aggressive companies since large acquisitions rarely create value for the shareholders. Contributors argue that Teva has overpaid for Actavis (its latest and largest acquisition) by at least $14B. This does not surprise us since most M&A deals are too expensive. Previous corruption issues add further doubts. Unfortunately, there is no amount of profit that can convince us to invest in a company where we do not like the management. We have sold our positions in Bayer (OTCPK:BAYZF) for similar reasons. We like Bayer, but we have sold our shares because of the Bayer-Monsanto (NYSE:MON) acquisition.

  • [By SEEKINGALPHA.COM]

    Other R&D products in Regeneron’s pipeline that we are interested in

    Fasinumab: Antibody against nerve growth factor, being developed for pain treatment like osteoarthritis. It is partnered with Teva Pharmaceutical (NASDAQ:TEVA) (for osteoarthritis, in phase 3), and is also being developed for treatment of chronic back pain. It is licensed to Mitsubishi Tanabe for the Japan territory. REGN2222: For prevention of RSV virus infection in infants, competing with Synagis from AstraZeneca (NYSE:AZN). Nesvacumab: Angiopoetin 2 antibody, being tested in combination with Eylea (in phase 2, partnered with Bayer (OTCPK:BAYZF)). Rinucumab (anti-PDGF): Being tested in treatment of wet AMD in combination with Eylea. Phase 2 trial was not successful, but the treatment duration was less (only 12 weeks versus 24 weeks for rival Ophthotech (NASDAQ:OPHT)). 28-week and 52-week data will be released later. With Ophthotech’s phase 3 failure with Fovista, we are bullish on Rinucumab’s commercial potential in wet AMD. Immuno-oncology pipeline: Checkpoint inhibitors and novel CAR-T; still in early stage.

    Click to enlarge

  • [By SEEKINGALPHA.COM]

    For the third quarter, the company reported cash and equivalents of $470.4 million, while net income came in at $50 million (includes a gain of $78.7 million from the Immunomedics’ warrant). Without the one-time gain, its loss of $28.7 million would still be an improvement over net loss of $31.8 million for the same quarter last year. For the fourth quarter, the company is guiding for ADCETRIS sales in the range of $82 million to $84 million (total revenue of $128 million to $130 million). In addition to the growing opportunity for ADCETRIS (peak sales in excess of $1 billion) and the intriguing prospects of tucatinib, the company has a promising pipeline of ADC candidates and immuno-oncology assets. Partnered programs with the likes of AbbVie (NYSE:ABBV), Astellas (OTCPK:ALPMY), Genmab (OTCPK:GMXAY), Bayer (OTCPK:BAYZF), Genentech and many more also lend additional credibility to the story.

  • [By SEEKINGALPHA.COM]

    And this is pretty important ground. Hepatocellular carcinoma can be managed with local therapy (surgery, embolization, etc.), but at its most advanced stages, the options quickly start to thin out. For a decade, the only option in systemic therapy was Bayer’s (OTCPK:BAYZF) sorafenib. Recently, the effective systemic treatment armamentarium was doubled with the approval of regorafenib for second-line therapy.

  • [By SEEKINGALPHA.COM]

    Online Direct Sales – Once only consumer electronics and mobile handsets, the products it offers has grown to include 15 different categories, including home appliances and a wide array of general merchandise.

    In April, JD.com became a certified member of the American Apparel & Footwear Association (AAFA), the trusted public policy and political voice of the apparel and footwear industry, a first for a Chinese e-commerce company. In the first quarter of 2017, Avene, the leading demo-cosmetic brand for sensitive skin in European pharmacies, and three brands under Georgio Armani launched flagship stores on JD.com’s direct sales platform. JD Worldwide, a cross-border e-commerce platform set up in April 2015 to provide access to international brands (including those not available in China), has retail contracts with international brands such as Wal-Mart (NYSE:WMT), Phillips, Barcelona FC, and GNC (NYSE:GNC). Recently, it’s partnered with ASDA, a leading UK retailer under the Wal-Mart umbrella, as well as Bayer (OTCPK:BAYZF) and Cetaphil. As of March 2017, it operates 263 warehouses covering a gross floor area of 5.8 million square meters. GMV from the online direct sales business was RMB107.9 billion in the first quarter of 2017, up 42% from the first quarter of 2016. Net revenues from online direct sales increased by 40% in the first quarter of 2017 as compared to the first quarter of 2016. Fulfilled orders in the first quarter of 2017 were 477.1 million, an increase of 39% from 342.1 million in the same period in 2016. Fulfilled orders placed through mobile accounted for approximately 81% of total orders fulfilled in the first quarter of 2017, an increase of 56% compared to the same period in 2016.

    Online Marketplace – Third-party sellers offer products to customers and pay a commission to JD.com. They provide transaction processing and billing services on all orders on the online marketplace and leverage their own nationwide fulfillment infrastructu

Top 10 High Tech Stocks To Invest In Right Now: Qualstar Corporation(QBAK)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggestedshorting small cap data storage systems stock Qualstar Corporation (NASDAQ: QBAK):

    Quelstar is essentially a mirror image of Pixelworks. That is, it’s not just the bearish undertow we want to tap into here. It’s the failure of QBAK to follow-through on today’s effort to break above the 100-day moving average line with today’s early effort. The market dared the bulls to play their hand, and as it turns out, they were bluffing. The sheer scope of the reversal bar in the meantime today confirms the downtrend.

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggestedpreemptively shorting small cap data storage systems stockQualstar Corporation (NASDAQ: QBAK):

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
  • [By Lisa Levin]

    Qualstar Corporation (NASDAQ: QBAK) was down, falling around 16 percent to $6.99. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 million.

Top 10 High Tech Stocks To Invest In Right Now: AFC Enterprises Inc.(AFCE)

Advisors’ Opinion:

  • [By AnnaLisa Kraft]

    AFC Enterprises (NASDAQ: AFCE  ) , which owns the Popeye’s Louisiana Kitchen quick- serve chain, once an undiscovered gem, has now soared 66% over the last year.

Top 10 High Tech Stocks To Invest In Right Now: Biogen Idec Inc(BIIB)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Biogen (BIIB) tumbled to the bottom of the S&P 500 today after getting cut by two analysts.

    Agence France-Presse/Getty Images

    Biogen dropped 4.7% to $278.96 at 4:19 p.m. today, while the S&P 500 declined 0.2% to 2,381.38.

    Leerinks Geoffrey Porges cited the “slower than expected ramp for Spinraza” in cutting Biogen to Market Perform from Outperform, while Morgan Stanly’s Matthew Harrison wrote that his decision to cut Biogen to Market Weight from Overweight was “not a downside call, but a timing call.”

    Biogen’s market capitalization fell to $60.2 billion today from $63.2 billion yesterday. It reported net income of $3.7 billion on sales of $10.2 billion in 2016.

    Barron’s Teresa Rivas recommended buying Biogen in December after the company released positive trial data on its Alzheimer’s drug.

  • [By WWW.MONEYSHOW.COM]

    Biogen (BIIB)

    Biogen discovers, develops and delivers innovative therapies for the treatment of neurodegenerative diseases and autoimmune disorders.

  • [By Brian Orelli]

    While that’s fine for clinical trials, it may make it difficult for Ionis’ drugs to compete with drugs that work as well but don’t have side effects that need to be monitored. Of course, for Spinraza, which Biogen (NASDAQ:BIIB) and Ionis recently got approved for spinal muscular atrophy, side effects aren’t an issue because there aren’t any other treatment options at the moment.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was Biogen Inc. (NASDAQ: BIIB) which traded down 4.6% at $279.08. The stocks 52-week range is $223.02 to $333.65. Volume was 3.4 million versus the daily average of 1.6 million shares.

Top 10 High Tech Stocks To Invest In Right Now: Flowserve Corporation(FLS)

Advisors’ Opinion:

  • [By Damon Churchwell]

    Increasing sales and margins
    A second, even larger, flow technology company to consider is Flowserve (NYSE: FLS  ) . The company’s flow control systems are utilized by a wide range of industries, led by oil & gas, chemicals, and power generation.

Top 10 High Tech Stocks To Invest In Right Now: ADDvantage Technologies Group, Inc.(AEY)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggestedshorting small cap cable television and telecommunications equipment stock ADDvantage Technologies Group, Inc (NASDAQ: AEY):

Top 10 High Tech Stocks To Invest In Right Now: Allegheny Technologies Incorporated(ATI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday morning, the basic materials shares climbed by 0.95 percent. Meanwhile, top gainers in the sector included Allegheny Technologies Incorporated (NYSE: ATI), up 5 percent, and Mechel PAO (ADR) (NYSE: MTL), up 5 percent.

  • [By Dan Caplinger]

    The stock market performed well on Tuesday, responding to steady improvement among many companies as earnings season kicked into high gear. Although political issues are likely to remain in the spotlight for some investors for the foreseeable future, many market participants are looking to economic and business issues in driving their investing decisions. Major market benchmarks finished the day with gains of 0.5% to 1%, but some stocks did much better. Among the best performers on the day were Allegheny Technologies (NYSE:ATI), II-VI (NASDAQ:IIVI), and Beazer Homes (NYSE:BZH). Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 High Tech Stocks To Invest In Right Now: China Jo-Jo Drugstores, Inc.(CJJD)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap Chinese retail pharmacy stock China Jo-Jo Drugstores (NASDAQ: CJJD) as a bullish long trade:

Top 10 High Tech Stocks To Invest In Right Now: St. Jude Medical, Inc.(STJ)

Advisors’ Opinion:

  • [By Emily Stewart]

    Paulson picked up 45,500 shares of St. Jude Medical (STJ) . The stake is worth $3.5 million as of the end of the second quarter.

    St. Jude Medical develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. It has a $23.6 billion market cap and trades at a P/E of 36.03. 

Top 10 High Tech Stocks To Invest In Right Now: BIG YELLOW GROUP PLC (BYLOF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The Big Yellow Group (OTC:BYLOF) recognized this opportunity back in 1998 when it was founded and has ever since been working towards bringing new supply of self-storage properties to the UK market. The strategy resulted in the following performance:

Best Energy Stocks To Invest In Right Now

San Francisco, CA, based Investment company Dodge & Cox buys Express Scripts Holding Co, Suncor Energy Inc, Bristol-Myers Squibb Company, Juniper Networks Inc, UBS Group AG, Cemex SAB de CV, News Corp, America Movil SAB de CV, sells Royal Dutch Shell PLC, NetApp Inc, Adient PLC, Symantec Corp, Unilever PLC during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Dodge & Cox. As of 2017-03-31, Dodge & Cox owns 179 stocks with a total value of $117.7 billion. These are the details of the buys and sells.

Added Positions: ESRX, SU, NVS, BMY, JNPR, UBS, AZN, CX, MDT, GOOG, Reduced Positions: SLB, RDS.A, HPQ, NTAP, BK, ADNT, SYMC, DVMT, BHI, GLW, Sold Out: HES, LOGM, LOW, MS,

For the details of Dodge & Cox’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Dodge+%26+Cox

These are the top 5 holdings of Dodge & CoxBank of America Corporation (BAC) – 185,448,539 shares, 3.72% of the total portfolio. Shares reduced by 1.47%Wells Fargo & Co (WFC) – 71,190,652 shares, 3.37% of the total portfolio. Shares reduced by 0.48%Charles Schwab Corp (SCHW) – 95,552,125 shares, 3.31% of the total portfolio. Shares reduced by 1.11%Capital One Financial Corp (COF) – 44,582,892 shares, 3.28% of the total portfolio. Shares reduced by 1.39%Novartis AG (NVS) – 50,585,790 shares, 3.19% of the total portfolio. Shares added by 10.65%Added: Express Scripts Holding Co (ESRX)

Dodge & Cox added to their holdings in Express Scripts Holding Co by 35.99%. Their purchase prices were between $63.84 and $73.16, with an estimated average price of $68.81. The stock is now traded at around $62.47. The impact to their portfolio due to this purchase was 0.43%. Their holdings were 28,800,496 shares as of 2017-03-31.

Best Energy Stocks To Invest In Right Now: St. Jude Medical, Inc.(STJ)

Advisors’ Opinion:

  • [By Emily Stewart]

    Paulson picked up 45,500 shares of St. Jude Medical (STJ) . The stake is worth $3.5 million as of the end of the second quarter.

    St. Jude Medical develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. It has a $23.6 billion market cap and trades at a P/E of 36.03. 

Best Energy Stocks To Invest In Right Now: Ideal Power Inc.(IPWR)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewslettersuggested smallcap electrical power conversion product stock Ideal Power Inc (NASDAQ: IPWR)as a long trade:

Best Energy Stocks To Invest In Right Now: QC Holdings Inc.(QCCO)

Advisors’ Opinion:

  • [By Monica Gerson]

    QC Holdings (NASDAQ: QCCO) shares tumbled 2.58% to reach a new 52-week low of $2.27. QC Holdings’ trailing-twelve-month profit margin is 0.60%.

    NewLead Holdings (NASDAQ: NEWL) shares dipped 6.56% to touch a new 52-week low of $0.08 after the company completed the acquisition of titles in the Viking Mine located in Kentucky, USA.